Literature DB >> 23242121

Cis-guggulsterone inhibits the IKK/NF-κB pathway, whereas trans-guggulsterone inhibits MAPK/AP-1 in MCF‑7 breast cancer cells: guggulsterone regulates MMP‑9 expression in an isomer-specific manner.

Eun-Mi Noh1, Eun Yong Chung, Hyun Jo Youn, Sung Hoo Jung, Hyun Hur, Young-Rae Lee, Jong-Suk Kim.   

Abstract

Νuclear factor-κB (NF-κB) and activator protein-1 (AP-1) are major transcription factors that have been associated with breast cancer metastasis by inducing matrix metalloproteinase-9 (MMP-9) expression. In this study, we investigated the inhibitory effects of guggulsterone isomers (cis or trans) on 12-O-tetradecanoylpho-bol-13-acetate (TPA)-induced MMP-9 expression. Cis-guggulsterone inhibited TPA-induced MMP expression by blocking IκB kinase (IKK)/NF-κB signaling, whereas trans-guggulsterone blocked mitogen-activated protein kinase (MAPK)/AP-1 signaling. Cis-guggulsterone was more potent than trans-guggulsterone in the inhibition of TPA-induced MMP-9 expression and invasion of MCF-7 cells. Furthermore, we found that the combination of these isomers exerted an additive effect on the inhibition of MCF-7 cell invasion. These results suggest that guggulsterone isomers downregulate MMP-9 expression and tumor cell invasion through the isomer-specific suppression of IKK/NF-κB and MAPK/AP-1 activation. In addition, the suppression of MMP-9 expression correlated well with the inhibition of cell invasion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242121     DOI: 10.3892/ijmm.2012.1214

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

1.  Salvia miltiorrhiza extract inhibits TPA-induced MMP-9 expression and invasion through the MAPK/AP-1 signaling pathway in human breast cancer MCF-7 cells.

Authors:  Jeong-Mi Kim; Eun-Mi Noh; Hyun-Kyung Song; Minok Lee; Soo Ho Lee; Sueng Hyuk Park; Chan-Keun Ahn; Guem-San Lee; Eui-Baek Byun; Beom-Su Jang; Kang-Beom Kwon; Young-Rae Lee
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

Review 2.  Potential therapeutic targets of Guggulsterone in cancer.

Authors:  Ajaz A Bhat; Kirti S Prabhu; Shilpa Kuttikrishnan; Roopesh Krishnankutty; Jayaprakash Babu; Ramzi M Mohammad; Shahab Uddin
Journal:  Nutr Metab (Lond)       Date:  2017-02-28       Impact factor: 4.169

3.  Myrrh induces the apoptosis and inhibits the proliferation and migration of gastric cancer cells through down-regulating cyclooxygenase-2 expression.

Authors:  Mengxue Sun; Jie Hua; Gaoshuang Liu; Peiyun Huang; Ningsheng Liu; Xiaopu He
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

Review 4.  Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer.

Authors:  Sosmitha Girisa; Dey Parama; Choudhary Harsha; Kishore Banik; Ajaikumar B Kunnumakkara
Journal:  Explor Target Antitumor Ther       Date:  2020-10-30

5.  Anti-inflammatory effects of guggulsterone on murine macrophage by inhibiting LPS-induced inflammatory cytokines in NF-κB signaling pathway.

Authors:  Jin-Hua Zhang; Zhao-Shui Shangguan; Chao Chen; Hui-Jie Zhang; Yi Lin
Journal:  Drug Des Devel Ther       Date:  2016-06-01       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.